Huge news on DIACTMOND PROJECT: we are happy to announce that we reached final phase of the work on DIACTMOND PROJECT – after successful testing in collaboration with our clinical partners at the Nicosia General Hospital, Embio Diagnostics’ scientists presented a final prototype of DIsease ACTivity MONitoring Device in our new laboratory.

EMBIO Diagnostics’ scientists made an incredibly large and important contribution to the future of disease diagnostics and monitoring, as with the help of the DIACTMOND only the single finger-prick blood drop will be used for the quantification of inflammation and blood coagulation levels. The information will be transferred to the treating physician through the network for assessment.

That is all for now. We will keep you updated with more news and photos soon.